Market Cap | 3.66M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
Income | -6.25M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | - |
Sales | 3.14M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -52.00% |
Dividend | N/A | Price/Book | 0.00 | EPS next 5Y | - | 52W High Chg | -98.00% |
Recommedations | - | Quick Ratio | 0.07 | Shares Outstanding | 8.51M | 52W Low Chg | 100.00% |
Insider Own | - | ROA | -174.77% | Shares Float | - | Beta | 0.47 |
Inst Own | 0.15% | ROE | - | Shares Shorted/Prior | -/- | Price | 0.00040 |
Gross Margin | 15.47% | Profit Margin | -198.99% | Avg. Volume | 420 | Target Price | - |
Oper. Margin | -184.75% | Earnings Date | - | Volume | 15 | Change | 0.00% |
Caliber Imaging & Diagnostics, Inc., a medical technologies company, designs, develops, and markets imaging solutions that shows tissue at the cellular level in the United States. The company provides VivaScope 1500, a reflectance confocal imaging system that enables clinicians and researchers to capture confocal images that depict cellular structures of living tissue; and VivaScope 3000, a hand-held in vivo reflectance confocal microscope for skin imaging. It also offers VivaScan software to schedule patients for examinations, perform imaging examinations on one or more lesions during a visit, review, and report on images obtained during an examination, as well as VivaNet, a digital telepathology system. The company was formerly known as Lucid, Inc. and changed its name to Caliber Imaging & Diagnostics, Inc. in August 2012. Caliber Imaging & Diagnostics, Inc. was founded in 1991 and is headquartered in Andover, Massachusetts.